ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Iowa » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Iowa

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SAADI ALBAGHDADI M.D.

Cardiovascular Disease

16,778

$802K

866
779 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 19%

$48
Average prescription price

Avg: $44

JOEL FROM M.D.

Cardiovascular Disease

15,620

$529K

1311
1158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 19%

$34
Average prescription price

Avg: $44

RANDOLPH ROUGH M.D.

Cardiovascular Disease

14,310

$621K

1415
1311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 19%

$43
Average prescription price

Avg: $44

MOHAMMAD PAYVANDI MD

Cardiovascular Disease

13,067

$799K

896
835 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 19%

$61
Average prescription price

Avg: $44

ANTHONY LAZAR M.D.

Cardiovascular Disease

12,201

$680K

790
738 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 19%

$56
Average prescription price

Avg: $44

HISHAM WAGDY MD

Cardiovascular Disease

9,874

$459K

705
636 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 19%

$47
Average prescription price

Avg: $44

THOMAS BRANDT M.D.

Cardiovascular Disease

9,287

$385K

722
669 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 19%

$41
Average prescription price

Avg: $44

DAVID LAUGHRUN M.D.

Cardiovascular Disease

9,045

$284K

989
868 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 19%

$31
Average prescription price

Avg: $44

KEITH KOPEC MD

Cardiovascular Disease

9,004

$367K

722
680 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 19%

$41
Average prescription price

Avg: $44

JOHN MEHEGAN MD

Cardiovascular Disease

7,723

$228K

623
570 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 19%

$30
Average prescription price

Avg: $44

LINDA LEE MD

Cardiovascular Disease

7,697

$228K

594
564 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 19%

$30
Average prescription price

Avg: $44

JEFFREY BOYD M.D.

Cardiovascular Disease

7,678

$264K

767
707 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 19%

$34
Average prescription price

Avg: $44

MARK WOODARD D.O.

Cardiovascular Disease

7,592

$400K

665
595 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 19%

$53
Average prescription price

Avg: $44

MARK BERRY D.O.

Cardiovascular Disease

7,578

$276K

1177
1045 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 19%

$36
Average prescription price

Avg: $44

STEPHAN SCHOMER MD

Cardiovascular Disease

7,394

$301K

508
480 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 19%

$41
Average prescription price

Avg: $44

MICHAEL MUELLERLEILE MD

Cardiovascular Disease

7,386

$317K

527
472 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 19%

$43
Average prescription price

Avg: $44

MOHAMMED KHALIL MD

Cardiovascular Disease

7,279

$307K

530
464 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 19%

$42
Average prescription price

Avg: $44

CRAIG STARK M.D.

Cardiovascular Disease

6,961

$389K

708
659 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 19%

$56
Average prescription price

Avg: $44

KATHLEEN KEYES M.D.

Cardiovascular Disease

6,888

$308K

561
479 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 19%

$45
Average prescription price

Avg: $44

STUART CHRISTENSON MD

Cardiovascular Disease

6,848

$361K

645
602 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 19%

$53
Average prescription price

Avg: $44

JAMES LOVELL D.O.

Cardiovascular Disease

6,841

$286K

669
604 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 19%

$42
Average prescription price

Avg: $44

DAVID LEMON M.D.

Cardiovascular Disease

6,801

$280K

681
616 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 19%

$41
Average prescription price

Avg: $44

ROBERT ARMBRUSTER M.D.

Cardiovascular Disease

6,774

$347K

713
614 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 19%

$51
Average prescription price

Avg: $44

M DOTANI M.D.

Cardiovascular Disease

6,734

$348K

613
568 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 19%

$52
Average prescription price

Avg: $44

AHMET ATAY MD

Cardiovascular Disease

6,614

$290K

546
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 19%

$44
Average prescription price

Avg: $44

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank